GE Healthcare posted strong sequential revenue and profit gains during the final three months of 2009, but full-year and Q4 numbers still lag year-ago figures.
GE Healthcare continues to recover from a sharp drop in hospital spending earlier in 2009, posting its best numbers of the year during the fourth quarter, but still trailed year-over-year comparisons during the three months ended Dec. 31.
The medical-equipment manufacturing unit at General Electric Co. (NYSE:GE) generated $4.7 billion in revenues during the quarter, up nearly $900 million from the previous three-month period. Segment profit topped the previous quarter by $403 million, or 79.3 percent, climbing from $508 million during the quarter ended Sept. 30, 2009, to $911 million over the final three months of the year.
GE officials said the healthcare unit benefited from "solid" growth in fourth-quarter orders, adding the unit began the new year with a larger backlog than it did at the start of 2009. GE Healthcare, which enjoyed productivity gains throughout the year, in April announced a $250 million, five-year partnership with Intel Corp. (NSDQ:INTC) to support new telemedicine initiatives while also completing the November acquisition of privately held ONI Medical Systems Inc., a Wilmington, Mass-based maker of specialty MRI devices.
Year-over-year comparisons were far less positive. Segment revenues and profits during the fourth quarter fell 2 percent and 3 percent, respectively, from $942 million in profits on $4.8 billion in revenues during the three months ended Dec. 31, 2008.
For the full year, revenues for the healthcare segment were $16 billion, down 8 percent from the $17.4 billion recorded during 2008. The 2009 segment profits of $2.4 billion marked a $118 million, or 15 percent, decline from $2.8 billion in profits at GE Healthcare in 2008.
GE Healthcare produces medical imaging, patient monitoring and diagnostics equipment as well as disease, drug and biopharmaceutical research and manufacturing tools.
Becton, Dickinson and Company's profits drop 10 percent during the third quarter on a $34...
Medtronic Inc. launches a global, randomized clinical trial of spinal cord stimulation as a treatment...
Baxter, Carefusion and Becton Dickinson among nine companies told by federal regulators to study...
Palomar Medical Technologies Inc. second quarter losses increases 600 percent due to heavy spending...
Chelmsford, Mass-based Zoll Medical Corp. records another strong quarter based on increased sales in...